PGS Testing 3rd Day Biopsy - 1 to 4 Embryos

In PGS Testing, a small sample of cells is taken from each embryo for genetic testing. This happens on the third day post-fertilization when the embryo is at the 6-8 cell stage. The cells are then examined in a lab to check for the correct number of chromosomes.

PGS Testing can identify chromosomal abnormalities such as Down syndrome (Trisomy 21), Edward’s syndrome (Trisomy 18), Patau syndrome (Trisomy 13), and others. It can also recognize any missing or additional chromosomes which could result in miscarriage or birth defects.

The risks associated with PGS Testing are minimal. However, there is a small chance that the embryo could be damaged during the biopsy process, but this is extremely rare with experienced practitioners.

If your PGS results indicate abnormalities, your healthcare provider will discuss the results with you and explain your options. These could include using a different embryo for implantation, considering the use of donor eggs or sperm, or considering options like adoption or surrogacy.

While PGS Testing significantly increases the chances of a successful pregnancy by identifying healthy embryos, it does not guarantee one. Other factors, like the age and overall health of the mother, also play a significant role.

PGS Testing can reduce the risk of miscarriages by ensuring that only embryos without chromosomal abnormalities are transferred to the uterus. However, it can't prevent all miscarriages as other factors might also contribute.

PGS Testing could be recommended if you've had recurrent miscarriages, unsuccessful IVF cycles, or if you're of advanced maternal age. It's a personal decision that should be discussed with your healthcare provider.

PGS Testing is highly accurate in detecting chromosomal abnormalities. However, like all tests, there is a small chance of false positives or negatives.

There is no specific preparation for PGS Testing. It is a part of the IVF process. However, regular communication with your healthcare provider during your IVF cycle is essential.

Yes, since PGS testing analyzes the chromosomes of the embryos, it can determine the sex of the baby. However, using PGS for gender selection raises ethical considerations and may not be allowed in all jurisdictions.

While PGS Testing can detect many chromosomal abnormalities, it cannot diagnose all genetic disorders. Some genetic diseases are caused by single gene mutations that are not detectable by PGS.

The risk of damaging the embryo during PGS Testing is extremely low. The procedure is done by experienced practitioners and does not harm the embryo's potential to develop into a healthy baby.

No, medications do not affect PGS Testing results. The test analyzes the chromosomes in the embryo's cells, which are not influenced by medications.

No, fasting is not required for PGS Testing. The test is part of the IVF process and involves analyzing the embryo's cells, not the patient's blood or urine.

Choosing to undergo PGS as part of your IVF cycle is a personal decision that should be carefully considered with your healthcare provider. By selecting embryos free of chromosomal abnormalities, PGS can potentially increase the chances of a successful pregnancy and reduce the risk of miscarriage or birth defects. However, PGS does not guarantee a successful pregnancy, and other factors also need to be considered.